SIC
BBNX

SJS Investment Consulting’s Beta Bionics BBNX Stock Holding History

SJS Investment Consulting’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.66K Buy
106
+100
+1,667% +$1.19K ﹤0.01% 1847
2026
Q1 		$61 Buy
+6
New +$89 ﹤0.01% 2226

Other funds holding BBNX

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
VFA
Values First Advisors Gray, Tennessee $219M AUM 33.35% 1-Year Est. Return
EF
Evanson Financial Mclean, Virginia $2.04B AUM
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
CG
Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return
GIA
Gladstone Institutional Advisory Palm Beach Gardens, Florida $3.16B AUM 29.04% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
IWM
Iams Wealth Management Omaha, Nebraska $332M AUM 18.77% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

SJS Investment Consulting's BBNX Position: Q2 2026 in Review

SJS Investment Consulting increased its Beta Bionics (BBNX) stake by 1,667% in Q2 2026, buying an estimated $1.19K and bringing the position to 106 shares worth $1.66K. The position accounts for ﹤0.01% of the portfolio, ranked #1847.

SJS Investment Consulting first reported a position in BBNX in Q1 2026 and has held it in 2 quarters since. 26 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • SJS Investment Consulting held 106 shares of Beta Bionics worth $1.66K as of Q2 2026.
  • SJS Investment Consulting bought 100 Beta Bionics shares in Q2 2026, an estimated $1.19K.
  • Beta Bionics made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1847 holding.
  • SJS Investment Consulting first reported a position in Beta Bionics in Q1 2026 and has held it in 2 quarters since.
  • 26 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.